Edward Cinca

Edward Cinca has a diverse work experience spanning over several industries. Edward currently holds the position of Chief Commercial Officer (CCO) at Radius Health, Inc. starting from October 2022. Prior to this, they served as the SVP, General Manager of Commercial Business at Currax Pharmaceuticals LLC from October 2021 to October 2022.

Edward has a long history with Novo Nordisk, where they held various leadership roles. Edward was the Vice President, Head of Cardiometabolic Marketing from October 2020 to July 2021. Previously, they served as the Vice President of the GLP-1 Portfolio from April 2017 to October 2020 and as the Vice President of Sales Execution from November 2015 to April 2017.

Edward's experience at Novo Nordisk also includes roles such as Senior Brand Director for Saxenda® from March 2013 to November 2015, Brand Director for Tresiba® and Ryzodeg® from February 2010 to March 2013, District Business Manager from January 2009 to February 2010, Associate Brand Director from January 2008 to December 2008, Sr. Brand Manager from July 2006 to December 2007, and Brand Manager from March 2004 to July 2006. Edward began their career at Novo Nordisk as a Management Associate from June 2003 to March 2004.

Edward also has experience working as a Consultant at Benchmark Technology Inc. from October 1998 to December 2001. Prior to that, they worked as a Lease Analyst at Smith Barney, Inc. from October 1995 to October 1998 and as an Accountant at ADP from May 1995 to October 1995.

Edward Cinca has a BS in Finance from Lehigh University, an MBA in Marketing and Finance from Fordham University, and a Certificate of Professional Development in Leadership from The Wharton School. Edward attended Bergen Catholic High School, but their degree and field of study are unknown.